Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID-19.
作者信息
Gould Susan, Norris Susan L
机构信息
Liverpool School of Tropical Medicine, UK.
Oregon Health & Science University, USA.
出版信息
Cochrane Database Syst Rev. 2021 Mar 25;3(3):ED000151. doi: 10.1002/14651858.ED000151.
Abstract
摘要
相似文献
1
Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID-19.有争议的效果与混乱的政策：2020年（羟）氯喹治疗新冠病毒病的故事
Cochrane Database Syst Rev. 2021 Mar 25;3(3):ED000151. doi: 10.1002/14651858.ED000151.
2
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.氯喹和羟氯喹治疗 COVID-19：一个永无止境的故事。
Appl Microbiol Biotechnol. 2021 Feb;105(4):1333-1343. doi: 10.1007/s00253-021-11094-4. Epub 2021 Jan 30.
3
Hydroxychloroquine Controversies: Clinical Trials, Epistemology, and the Democratization of Science.羟氯喹争议：临床试验、认识论与科学民主化。
Med Anthropol Q. 2020 Dec;34(4):525-541. doi: 10.1111/maq.12622. Epub 2020 Nov 18.
4
Chloroquine as a prophylactic agent against COVID-19?氯喹作为 COVID-19 的预防药物？
Int J Antimicrob Agents. 2020 Jun;55(6):105980. doi: 10.1016/j.ijantimicag.2020.105980. Epub 2020 Apr 12.
5
6
Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19.羟氯喹和氯喹：治疗 COVID-19 的潜在且具争议性的药物。
Arch Pharm Res. 2020 Aug;43(8):765-772. doi: 10.1007/s12272-020-01258-7. Epub 2020 Aug 1.
7
An overview of antiviral strategies for coronavirus 2 (SARS-CoV-2) infection with special reference to antimalarial drugs chloroquine and hydroxychloroquine.冠状病毒 2（SARS-CoV-2）感染的抗病毒策略概述，特别提到抗疟药物氯喹和羟氯喹。
Int J Clin Pract. 2021 Mar;75(3):e13825. doi: 10.1111/ijcp.13825. Epub 2020 Nov 22.
8
Knowing more about chloroquine/hydroxycloroquine in COVID-19 patients.进一步了解新冠病毒肺炎患者使用氯喹/羟基氯喹的情况。
Future Microbiol. 2020 Oct;15:1523-1526. doi: 10.2217/fmb-2020-0247. Epub 2020 Nov 18.
9
What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.（羟）氯喹对抗 COVID-19 无效的原因：细胞生物学的见解。
J Mol Cell Biol. 2021 Jul 6;13(3):175-184. doi: 10.1093/jmcb/mjab016.
10
Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.为何您的患者认为羟氯喹和氯喹对新冠病毒病有90%的疗效是极其危险的。
J Clin Pharmacol. 2020 Aug;60(8):949-953. doi: 10.1002/jcph.1687. Epub 2020 Jul 1.
引用本文的文献
1
The impact of the COVID-19 pandemic on antimicrobial usage: an international patient-level cohort study.新型冠状病毒肺炎大流行对抗菌药物使用的影响：一项国际患者水平队列研究。
JAC Antimicrob Resist. 2025 Mar 26;7(2):dlaf037. doi: 10.1093/jacamr/dlaf037. eCollection 2025 Apr.
2
Retinal Toxicity from Chronic Hydroxychloroquine use in Kenya.肯尼亚慢性羟氯喹使用导致的视网膜毒性。
Ann Afr Med. 2022 Jul-Sep;21(3):301-304. doi: 10.4103/aam.aam_118_21.
3
COVID-19 and first manic episodes: a systematic review.COVID-19 与首次躁狂发作：系统综述。
Psychiatry Res. 2022 Aug;314:114677. doi: 10.1016/j.psychres.2022.114677. Epub 2022 Jun 9.
4
IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives.白细胞介素-6 在头颈部癌症生态系统中的作用：可能的治疗前景。
Int J Mol Sci. 2021 Oct 13;22(20):11027. doi: 10.3390/ijms222011027.
本文引用的文献
1
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.氯喹或羟氯喹预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
2
How a torrent of COVID science changed research publishing - in seven charts.新冠科学洪流如何改变研究出版——用七张图表展示
Nature. 2020 Dec;588(7839):553. doi: 10.1038/d41586-020-03564-y.
3
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.用于治疗新冠肺炎的抗病毒药物 repurposed - 世界卫生组织团结试验中期结果
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
4
Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation.在非洲，违反世界卫生组织的建议将氯喹和羟氯喹用于治疗新冠肺炎的非标签用药情况。
Res Rep Trop Med. 2020 Sep 17;11:61-72. doi: 10.2147/RRTM.S269936. eCollection 2020.
5
"Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors - A survey".印度医生对印度国家特别工作组新冠疫情建议的遵循情况调查
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1413-1418. doi: 10.1016/j.dsx.2020.07.040. Epub 2020 Jul 25.
6
The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for Pharmacovigilance.COVID-19“信息疫情”对药物利用行为的影响：对药物警戒的启示。
Drug Saf. 2020 Aug;43(8):699-709. doi: 10.1007/s40264-020-00965-w.
7
Caution and clarity required in the use of chloroquine for COVID-19.使用氯喹治疗新冠病毒疾病（COVID-19）时需谨慎并明确用法。
Lancet Rheumatol. 2020 May;2(5):e255. doi: 10.1016/S2665-9913(20)30093-X. Epub 2020 Apr 2.
8
Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤稿——羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎：一项多国注册研究分析
Lancet. 2020 Jun 13;395(10240):1820. doi: 10.1016/S0140-6736(20)31324-6. Epub 2020 Jun 5.
9
[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].羟氯喹治疗中度新型冠状病毒肺炎患者的一项试点研究
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219. doi: 10.3785/j.issn.1008-9292.2020.03.03.
10
COVID-19 and Fake News in the Dominican Republic.新冠疫情和多米尼加共和国的假新闻。
Am J Trop Med Hyg. 2020 Jun;102(6):1172-1174. doi: 10.4269/ajtmh.20-0234.
Zotero 插件